Logo

What's a joke you haven't used yet, but are dying to share?

Last Updated: 29.06.2025 00:31

What's a joke you haven't used yet, but are dying to share?

Next, they tried...

Still no good

Dr.Smith was a Psychiatrist & Dr.Jones was a Proctologist (Colon to Anus)

South Florida-based Silver Airways shuts down, stranding travelers - Sun Sentinel

Another attempt resulted in ...

Schizoids & Haemorrhoids

share office space ...

What are the signs of mild autism in a child?

Thumbs down again.

Almost at their wits end, the docs finally came up with...

Loons and Moons

What would TERFs do if there weren't such a thing as being transgender? Who would be their target?

Two best friends graduated from medical school at the same time & decided that in spite of two different specialties, they would open a practice together to

Dr.Smith & Dr.Jones...

So they tried

How did you as a human being change while growing up?

Hysterias & Posteriors

Analysis & Anal Cysts

This was also not acceptable, so they again changed the sign to

Nintendo Switch 2 Welcome Tour Review - IGN

I hope you enjoy this as much as I did.

Just Forget it!

Freaks and Cheeks

Stanford Scientists Develop Game-Changing New Way To Treat Stroke - SciTechDaily

Dr.Smith & Dr.Jones

Unacceptable again!

No way

Is it ok for someone to crossdress in public?

The town council was livid and insisted they change it.

Lost Souls & Butt Holes

So, the docs changed it to read

Gucci Owner Picks Auto Executive for One of Global Luxury’s Top Jobs - WSJ

Everyone loved it.

Minds and Behinds

Then came..

Dollar Tree raises red flag about unexpected customer behavior - TheStreet

They put up a sign reading

No, not a chance

Manic Depressives & Anal Retentives

Food and fitness make or break success on weight loss meds, report finds - ABC News

Specializing in Odds & Ends.

Nuts and Butts

No go.

Fog of trade war hangs over economy, but the Fed still has to make a forecast. Here’s what it’s faces. - MarketWatch

Catatonics & High Colonics

Still no good.

The decades-long journey to Gilead’s twice-a-year HIV prevention drug lenacapavir - STAT